This inventor holds 1 USPTO granted patent. Top assignee: University of Colorado. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Christopher J Matheson: Innovator in Cancer Treatment
Introduction
Christopher J Matheson is a notable inventor based in Newcastle upon Tyne, GB. He has made significant contributions to the field of cancer treatment through his innovative research and development of pharmaceutical compounds.
Latest Patents
Matheson holds a patent for AMP-activated protein kinase inhibitors and methods of making and using the same. This patent relates to compounds of Formula (I), including stereoisomers, prodrugs, and pharmaceutically acceptable salts. The compounds are designed to inhibit AMP-Activated protein kinase (AMPK) and have potential applications in treating cancer in subjects.
Career Highlights
Christopher J Matheson is affiliated with the University of Colorado, where he continues to advance his research in the field of biochemistry and pharmacology. His work focuses on developing innovative solutions for complex medical challenges.
Collaborations
Some of his notable coworkers include Philip Reigan and Craig T Jordan, who contribute to the collaborative efforts in research and development within the university.
Conclusion
Christopher J Matheson is a dedicated inventor whose work in developing AMPK inhibitors showcases his commitment to advancing cancer treatment. His contributions to the field are invaluable and highlight the importance of innovation in medical research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile